Beck Joanne T.
SEC insider (Form 3/4/5 filer). CIK 0001768045. Director at Astria Therapeutics, Inc. (ATXS). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.
Companies Beck Joanne T. has filed insider reports for
- Astria Therapeutics, Inc. (ATXS): Director
Beck Joanne T.
CIK: 0001768045
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Astria Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
16.7K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
8.3K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
26.6K shares- - Jun 11, 2025ATXS
Astria Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
26.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 16,666 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 8,333 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 26,550 | - | - | Direct |
| Jun 11, 2025 | ATXS Astria Therapeutics, Inc. | Award Stock Option (Right to Buy) | 26,550 | - | - | Direct |
1-6 of 6 transactions